Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
11/2005
11/17/2005WO2005007843B1 Amino acid-substituted coagulation factor v
11/17/2005WO2004078140A3 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
11/17/2005WO2003087321A8 Plant acyl-coa synthetases
11/17/2005US20050257291 Genes coding for a protein having a glycoside transfer activity
11/17/2005US20050257290 Nematode fatty acid desaturase-like sequences
11/17/2005US20050257289 AP2 domain transcription factor ODP2 (ovule development protein 2) and methods of use
11/17/2005US20050257288 Generation of plants with altered oil content
11/17/2005US20050257285 Compositions and methods for the treatment of Pierce's disease
11/17/2005US20050257284 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants
11/17/2005US20050257276 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
11/17/2005US20050256057 Proline-specific endoprotease and tripeptidase digested polypeptide mixture comprising tripeptides for use in pharmaceuticals and nutraceuticals
11/17/2005US20050256033 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
11/17/2005US20050255576 PGDS inhibitor; antiallergies, sleep control, antiobesity and brain wound healing; Crystals of a complex of human origin hematopoietic prostaglandin D synthase, glutathione and a substrate analog or an inhibitor
11/17/2005US20050255575 Reacting a vinyl halide and an acetylene compound in the presence of a copper (1) bidentate ligand complex, e.g., Cu(1,10-phenanthrolene)(triphenylphosphine)2NO3 and a CuI/neocuproine reaction product; free of expensive palladium reagents
11/17/2005US20050255574 Proteins
11/17/2005US20050255571 Biocatalysts in chemical reactions, activity, stability and enantioselectivity; for the preparation of optically active compounds
11/17/2005US20050255568 Methods and compositions for amino acid production
11/17/2005US20050255567 Mutant glutamine synthetase and method for producing amino acids
11/17/2005US20050255566 Nucleotide sequences coding enzymatic polypeptide; for use in generation of preferential amino acids
11/17/2005US20050255564 Sulfated fucan
11/17/2005US20050255554 Fusion peptides isolatable by phase transition
11/17/2005US20050255549 IRAK-4: compositions and methods of use
11/17/2005US20050255544 Lipolytic enzyme variants and method for their production
11/17/2005US20050255542 Expressing a thioredoxin-fused membrane protein, particularly a G protein-coupled receptor, in a cell-free system that preferably contains a nonionic detergent
11/17/2005US20050255541 Method for hydrolysing carotenoids esters
11/17/2005US20050255521 59079 and 12599, protein kinase family members and uses therefor
11/17/2005US20050255520 Cardiac-related Ankyrin-Repeat Protein Kinase (CARK); specifically binds to polypeptide encoded by nucleic acid; labeled or conjugated to therapeutic agent; treatment of cardiovascular disorders
11/17/2005US20050255516 Method for quantitative analysis of a nucleic acid amplification reaction
11/17/2005US20050255513 Regulatable growth of filamentous fungi
11/17/2005US20050255497 Gene for coding thermostable L-arabinose isomerase and method for producing the same
11/17/2005US20050255489 nucleotide sequence encoding a polypeptide having N-acetylglucosaminyl transferase V activity called Vb, useful in in vitro enzymatic reactions of this enzyme and in recombinant host cells for the production of glycoproteins with more efficient and extensive glycosylation
11/17/2005US20050255204 Method and composition for the prevention or retarding of staling and its effect during the baking process of bakery products
11/17/2005US20050255162 Hydrophobic biomolecular structure
11/17/2005US20050255099 Antigenic fusion protein carrying Galalpha 1,3Gal epitopes
11/17/2005US20050255094 Mitogen-activated protein kinase kinase MEK6 and methods of use therefor
11/17/2005US20050255093 treating nervous system disorders induced by stroke or injury, injured by trauma to reduce oxidative stress, administering a conjugate of antioxidant enzyme and a clostridial neurotoxin cell binding domain, and a clostridial neurotoxin translocation domain; tissue-targeted therapy
11/17/2005US20050255090 High enzyme activity; screening its relative symbiotic bacteria using a specific antibody
11/17/2005DE102004019751A1 Neue Alkalische Proteasen und Wasch- und Reinigungsmittel, enthaltend diese neuen Alkalischen Proteasen New Alkaline proteases and detergents and cleaning agents containing these novel alkaline proteases
11/17/2005CA2569083A1 Detecting disease association with aberrant glycogen synthase kinase 3.beta. expression
11/17/2005CA2566189A1 Mutant saccharomyces cerevisiae strain utilizing xylose for ethanol production
11/17/2005CA2563206A1 Novel herbicide resistance genes
11/17/2005CA2562552A1 Hybrid recombinases for genome manipulation
11/17/2005CA2538837A1 Modified xylanases having increased thermostability and alkaline stability
11/16/2005EP1595957A1 Phosphoglycerate mutases and enzyme products
11/16/2005EP1595956A1 Process for an enzymatic oxygenation by direct electrochemical regeneration of the FAD-dependent monooxygenase
11/16/2005EP1595955A1 Beta 1,3-n-acetyl-d-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same
11/16/2005EP1595954A1 Human papilloma virus inhibition by antisense oligonucleotides
11/16/2005EP1595950A1 Method of measuring homocysteine
11/16/2005EP1595949A1 Method of degrading plastic and process for producing useful substance using the same
11/16/2005EP1595947A1 MN gene and protein
11/16/2005EP1595946A2 STE20-related protein kinases
11/16/2005EP1595945A1 Screening method for identifying compounds that have the ability to inhibit the activity of Myc
11/16/2005EP1595447A1 Transgenic animal having fatty acid desaturase and method of producing the same
11/16/2005EP1594989A2 Methods for the early diagnosis of ovarian cancer
11/16/2005EP1594967A1 MICROBIAL PRODUCTION OF C sb O /sb Q10
11/16/2005EP1594963A2 Proteases
11/16/2005EP1594962A2 Covalent tethering of functional groups to proteins
11/16/2005EP1594961A2 Glyphosate resistant class i 5-enolpyruvylshikimate-3-phosphate synthase (epsps)
11/16/2005EP1594960A2 Human cyclooxygenase-3 and uses thereof
11/16/2005EP1594959A2 Novel therapeutic method and compositions for topical administration
11/16/2005EP1594855A2 Signalling compounds for use in methods of detecting hydrogen peroxide
11/16/2005EP1594439A2 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS
11/16/2005EP1539800A4 Thrombin peptide derivative dimers
11/16/2005EP1487974A4 Nad phosphite oxidoreductase a novel catalyst from bacteria for regeneration of nad(p)h
11/16/2005EP1487472A4 Stabilization of hypoxia inducible factor (hif) alpha
11/16/2005EP1463823A4 Methods of increasing endogenous erythropoietin (epo)
11/16/2005EP1399568B1 Method for producing recombinant trypsin
11/16/2005EP1358315A4 Identification of an advanced sleep phase syndrome gene in humans
11/16/2005EP1322786A4 Method of identifying putative antibiotic resistance genes
11/16/2005EP1294927B1 Screening-method for modulators of methyltransferase-dependent chromosome stability
11/16/2005EP1153135B1 Methods for modulating the levels of organic sulfur compounds in plants
11/16/2005EP1131090B1 Use of paraoxanase-1 (pon-1) to decrease atheroma formation and hypercholesterolemia
11/16/2005EP1109823B1 Modifications of the vegf receptor-2 protein and methods of use
11/16/2005EP1007066B1 Screening methods for glucocorticoid receptor binding substances using trypterygium wilfordii preparations
11/16/2005EP0939799B1 Enzymatic cofactor cycling using soluble pyridine nucleotide transhydrogenase
11/16/2005EP0871746B1 Carboxypeptidases from aspergillus oryzae and nucleic acids encoding same
11/16/2005EP0832232B1 Kunitz type plasma kallikrein inhibitors
11/16/2005EP0818532B1 Plant promoter and gene expression with the use of the same
11/16/2005EP0788547B1 Purified coprinus laccases and nucleic acids encoding same
11/16/2005CN1697877A Xylanases with enhanced thermophilicity and alkalophilicity
11/16/2005CN1696284A Method for extracting trypsase in intestinal alimentary canal of chicken
11/16/2005CN1227363C Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same
11/16/2005CN1227359C Down-regualtion resistant C3 convertase
11/16/2005CN1227345C Laundry detergent compositions with cationically charged dye maintenance polymer
11/16/2005CN1227226C Preparation of Lactams from aliphatic alpha, omega-dinitriles
11/16/2005CN1227025C Improved methods for processing activated protein C
11/16/2005CN1226936C Carbohydrate-based enzyme granulates
11/15/2005US6965022 Methods to identify swine genetically resistant to F18 E. coli associated diseases
11/15/2005US6965021 Nucleotide sequences coding enzymatic polypeptide for use in the generation of preferential amino acids
11/15/2005US6964957 For use in therapy of neurodegenerative diseases and certain cancers
11/15/2005US6964944 Chemically modified lipolytic enzyme
11/15/2005US6964865 Host cells comprising Streptomyces clavuligerus chromosomal DNA fragments encoding enzymes for β-lactam antibiotic biosynthesis
11/15/2005US6964863 Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses
11/15/2005US6964849 Proteins and nucleic acids encoding same
11/15/2005US6964764 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
11/15/2005CA2292514C Detersive enzyme particles having water-soluble carboxylate barrier layer and compositions including same
11/15/2005CA2162481C Marker gene
11/14/2005CA2467312A1 Inhibition of the trnalys3-primed initiation of reverse transcription in hiv-1 by apobec3g
11/13/2005CA2507567A1 Use of compositions comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions
11/12/2005CA2507175A1 Tridimensional simultaneous measurement machine
1 ... 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 ... 1416